Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Comment by Clipper2on Aug 16, 2020 8:14pm
201 Views
Post# 31415705

RE:RE:Some promising studies on psychedelic drugs

RE:RE:Some promising studies on psychedelic drugs
newcoin wrote: Thanks.

I set my PVR.

I wonder if there will be specific companies  mentioned?


Hi newcoin
They didn't mention any companies but covered the subject quite well considering the short amount of time they had. Rolland Griffiths and Michael Pollan were on the show. Funnily enough I have just finished reading Pollan's book " How to change your mind" which is all about psilocybin and LSD and the trials which are ongoing. I have read a few books on the subject and Pollan's is by far the best, and I definately recommend it. The book can be downloaded for free as a pdf.
BTW I am fairly new to this stock and bought in a couple of weeks prior to the halt. (bummer) As part of my dd I read all the bb posts from the beginning and your posts (newcoin) stood out as some of the best. Thank you.
GL

<< Previous
Bullboard Posts
Next >>